Structure-based development of specific inhibitors for individual cathepsins and their medical applications (Q34598268)

3 August 2017

2 references

28 September 2019

2 October 2019

Structure-based development of specific inhibitors for individual cathepsins and their medical applications (English)

1 reference

3 August 2017

1 reference

28 September 2019

1 reference

2 October 2019

Nobuhiko Katunuma

1

1 reference

PubMed ID

21321479

3 August 2017

language of work or name

1 reference

1 January 2011

1 reference

Proceedings of the Japan Academy, Series B

3 August 2017

3 references

3 August 2017

28 September 2019

2 October 2019

87

1 reference

3 August 2017

29-39

1 reference

3 August 2017

2

1 reference

Cathepsin L activity controls adipogenesis and glucose tolerance

3 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043741

Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043741

Lysosomal cysteine proteases: facts and opportunities

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043741

Inhibition mechanism of cathepsin L-specific inhibitors based on the crystal structure of papain-CLIK148 complex

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043741

Switch of CD4+ T cell differentiation from Th2 to Th1 by treatment with cathepsin B inhibitor in experimental leishmaniasis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043741

Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043741

Action of rat liver cathepsin L on collagen and other substrates

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043741

The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043741

Structure-based design of specific cathepsin inhibitors and their application to protection of bone metastases of cancer cells

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043741

Pepstatin A-sensitive aspartic proteases in lysosome are involved in degradation of the invariant chain and antigen-processing in antigen presenting cells of mice infected with Leishmania major.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3043741

Inhibition of intracellular cathepsin activities and suppression of immune responses mediated by helper T lymphocyte type-2 by peroral or intraperitoneal administration of vitamin B6

26 October 2018

1 reference

12 December 2020

Chymostatin, a new chymotrypsin inhibitor produced by actinomycetes

1 reference

12 December 2020

Biosynthesis of leupeptin

1 reference

12 December 2020

Inhibitions by E-64 derivatives of rat liver cathepsin B and cathepsin L in vitro and in vivo

1 reference

12 December 2020

IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells

1 reference

12 December 2020

In vivo and in vitro evidence for the involvement of cysteine proteinases in bone resorption

1 reference

12 December 2020

Effect of proteinase inhibitors on intracellular processing of cathepsin B, H and L in rat macrophages

1 reference

12 December 2020

Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro

1 reference

12 December 2020

Structure, properties, mechanisms, and assays of cysteine protease inhibitors: cystatins and E-64 derivatives

1 reference

12 December 2020

Structure based development of novel specific inhibitors for cathepsin L and cathepsin S in vitro and in vivo

1 reference

12 December 2020

Critical role of cathepsin-inhibitors for autoantigen processing and autoimmunity

1 reference

12 December 2020

Structure-based development of pyridoxal propionate derivatives as specific inhibitors of cathepsin K in vitro and in vivo

1 reference

12 December 2020

Identifiers

DOI

10.2183/PJAB.87.29

1 reference

3 August 2017

1 reference

3 August 2017

1 reference

PubMed ID

21321479